neutralizing antibody against il-17 (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
90
Structured Review
Bio X Cell
neutralizing antibody against il-17
Neutralizing Antibody Against Il 17, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neutralizing+antibody+against+il-17/anti+il+17a+17f3/pmc10705600-429-13-16
Average 90 stars, based on 1 article reviews
Neutralizing Antibody Against Il 17, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neutralizing+antibody+against+il-17/anti+il+17a+17f3/pmc10705600-429-13-16
Average 90 stars, based on 1 article reviews
neutralizing antibody against il-17 - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "“MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity”"
Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity”
Journal: Research Square
doi: 10.21203/rs.3.rs-3644984/v1
Figure Legend Snippet:
Techniques Used: Purification, Recombinant, Control, Activation Assay, Staining, Reverse Transcription, SYBR Green Assay, Lysis, Protease Inhibitor, Electron Microscopy, Injection, Enzyme-linked Immunosorbent Assay, Bicinchoninic Acid Protein Assay, Plasmid Preparation, Software
Related Articles
Neutralization:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Purification:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Recombinant:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Control:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Activation Assay:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Staining:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Reverse Transcription:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing SYBR Green Assay:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Lysis:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Protease Inhibitor:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Electron Microscopy:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Injection:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Enzyme-linked Immunosorbent Assay:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Bicinchoninic Acid Protein Assay:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Plasmid Preparation:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing Software:Article Title: “MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity” Article Snippet: For cytokine neutralization experiments, mice were treated intraperitoneally (i.p.) with 500μg of neutralizing |